John Chang
· MDUniversity of California, San Diego · Gastroenterology
Active 1998–2025
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Dr. John Chang studies the cellular and molecular mechanisms underlying T lymphocyte fate specification. His research focuses on understanding how activated T lymphocytes give rise to differentially fated progeny, addressing a central problem faced by multi-cellular organisms: the need for rare progenitor cells to continually produce terminally differentiated cells while preserving a self-renewing lineage. In the mammalian immune system, this challenge is exemplified by T lymphocytes, which must simultaneously differentiate and regenerate. Dr. Chang's work aims to elucidate the molecular mechanisms that enable this balance in T lymphocyte populations. He has been recognized with several prestigious awards, including the HHMI Physician-Scientist Early Career Award, the NIH Director's New Innovator Award, and the AGA-GRG Young Investigator Award in Basic Science. Additionally, Dr. Chang has been elected to the American Society for Clinical Investigation (ASCI) and is supported by grants from the National Institutes of Health and the Kenneth Rainin Foundation.
Research topics
- Biology
- Genetics
- Immunology
- Medicine
- Bioinformatics
- Pathology
- Neuroscience
- Biochemistry
- Computational biology
- Chemistry
Selected publications
Pathophysiology of Inflammatory Bowel Diseases
New England Journal of Medicine · 2020 · 1223 citations
1st authorCorrespondingResearch on IBDs has identified disrupted immune responses in the gastrointestinal mucosa and putative disruptions in the gut microbiome as causative agents. This work has led to better therapeutic control of IBDs with the use of various antiinflammatory agents.
Global chemical effects of the microbiome include new bile-acid conjugations
Nature · 2020 · 581 citations
Immunity · 2020 · 286 citations
Science Immunology · 2020 · 274 citations
Senior authorCorrespondingcells in IBD.
Metabolic programs of T cell tissue residency empower tumour immunity
Nature · 2023-08-30 · 121 citations
articleOpen access
Recent grants
NIH · $699k · 2014
Role of proteasome activity in adaptive immunity
NIH · $2.2M · 2017–2023
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
NIH · $1.7M · 2012–2018
Frequent coauthors
- 64 shared
Brigid S. Boland
- 52 shared
Steven L. Reiner
Columbia University Irving Medical Center
- 38 shared
Ichiko Kinjyo
University of New Mexico
- 35 shared
Sarah M. Russell
Peter MacCallum Cancer Centre
- 32 shared
William J. Sandborn
- 31 shared
Jane Oliaro
Peter MacCallum Cancer Centre
- 29 shared
V. Palanivel
- 28 shared
Ananda W. Goldrath
University of California, San Diego
Similar researchers at University of California, San Diego
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with John Chang
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
